ArticleFrontiers in oncology2025
Scrotal hemangioma: a case report and systematic literature review.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aimed to provide a case of scrotal hemangioma and examine its characteristics. Methods: We presented a case report involving a sixteen-year-old male, detailing symptoms, physical examination, imaging studies, diagnosis, and treatment. We conducted a thorough literature analysis of case reports and examined their clinical characteristics, pathological categorization, recurrence, and complications. Results: Our study comprised 21 patients with scrotal hemangioma. The average age was 27.14 years, with a range from 21 days to 84 years. 57.1% of the hemangiomas affected the organs. 61.9% of patients were situated on the right side of the scrotum. Ninety percent of patients experienced no pain. Merely 33.3% of patients exhibited additional symptoms, which encompassed azoospermia, hemorrhage, calcification, hydrocele, thrombosis, and ulceration. The predominant pathological classification was cavernous scrotal hemangioma, representing 38.1% of the cases. All patients received surgical resection, and the majority experienced neither relapse nor postoperative complications. Conclusions: Scrotal hemangioma, an uncommon benign neoplasm in adolescents, frequently remains asymptomatic but may disrupt fertility and, in rare instances, lead to severe problems. Timely identification, diagnosis, and surgical intervention are essential for good patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.